🔍
Search Results - paul+talalay
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Broad Spectrum Chemoprotective Activities of Exemstane Against Cancer and Other Chronic Diseases: Synergism with Sulforaphane
Estrogens control the growth and development of the majority of breast cancers, the most prevalent malignancies of women in the developed world. Exemestane, a synthetic steroid commonly used clinically to prevent, delay progression of, and treat breast cancer, was designed to inhibit estrogen biosynthesis by aromatase. We have made the unexpected observation...
Published: 3/13/2025
|
Inventor(s):
Hua Liu
,
Paul Talalay
Keywords(s):
Antagonists/Inhibitors
,
Cancers
,
Chemotherapy/Chemotherapy
,
Combination
,
Disease Indication
,
Natural compounds
,
Non-novel
,
Predicted Novelty
,
Small Molecules
,
Therapeutic Matter
,
Therapeutic Substance
,
Therapeutics
,
Therapy Type
Category(s):
Clinical and Disease Specializations
,
Clinical and Disease Specializations > Oncology
,
Technology Classifications > Therapeutic Modalities > Small Molecules
,
Technology Classifications > Therapeutic Modalities
Prevention of Alcohol Toxicity
C11719: Drug to Prevent Alcohol ToxicityNovelty: The technology involves the use of dietary chemicals to reduce the unpleasant symptoms associated with alcohol consumption and reduce the risk of serious diseases.Value Proposition: Alcohol toxicity from the consumption of a large amount of alcohol in a short period of time can lead to many adverse symptoms...
Published: 3/13/2025
|
Inventor(s):
Yusuke Ushida
,
Paul Talalay
Keywords(s):
Disease Indication
,
Metabolic Disorders
,
Therapeutic Matter
,
Therapeutic Substance
,
Therapeutics
Category(s):
Clinical and Disease Specializations
,
Clinical and Disease Specializations > Metabolic Diseases
,
Technology Classifications > Therapeutic Modalities > Nutritional Compounds
,
Technology Classifications > Therapeutic Modalities > Repurposed Drugs
,
Technology Classifications > Therapeutic Modalities
JHTV Home
|
Search
|
Login/Subscribe
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by
Inteum